drugset / Trial / NCT00026468

Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis

NCT00026468 ↗

RandomizedSingle-groupDouble-blindPrevention

Summary

RATIONALE: Exisulind may be effective in preventing the development and growth of polyps in patients who have familial adenomatous polyposis. PURPOSE: Randomized phase II/III trial to determine the effectiveness of exisulind in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.

Timeline

Start
1999-07
Primary completion
1999-07
Completion
1999-07

Outcome

Outcome not reported

Stopped: “Principle Investigator has left the University.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Exisulind Small molecule — Oral